HuGE Literature Finder
Records 1-3
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Apr 21 (7): 1583-90. Bohanes Pierre, Rankin Cathryn J, Blanke Charles D, Winder Thomas, Ulrich Cornelia M, Smalley Stephen R, Rich Tyvin A, Martensen James A, Benson Al B, Mayer Robert J, Cripps Christine M, Danenberg Kathleen, Makar Karen W, Zhang Wu, Benedetti Jacqueline K, Lenz Heinz-Jos |
The final results of the SWOG S9304 phase III intergroup trial's pharmacogenetic analysis: Association of polymorphisms with survival and toxicity in stage II/III rectal cancer patients treated with 5-fluorouracil (5-FU) and pelvic radiation (RT).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 3542. Wilson P M, Bohanes P O, Rankin C J, Benedetti J K, Ulrich C M, Smalley S R, Makar K W, Zhang W, Winder T, Ning Y, Gerger A, Benhaim L, El-Khoueiry R, Labonte M J, Blanke C D, Lenz |
Genotype Frequencies of Cyclooxygenease 2 (COX2) Rare Polymorphisms for Japanese with and without Colorectal Cancer.
Asian Pacific journal of cancer prevention : APJCP 2001 2 (1): 57-62. Hamajima Nobuyuki, Takezaki Toshiro, Matsuo Keitaro, Saito Toshiko, Inoue Manami, Hirai Takashi, Kato Tomoyuki, Ozeki Junko, Tajima Kaz |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: